Effect of Omeprazole on the Pharmacokinetics of SHR6390 in Healthy Subjects
Status:
Not yet recruiting
Trial end date:
2021-11-15
Target enrollment:
Participant gender:
Summary
This is a one-arm, fixed-sequence study to compare the pharmacokinetic profiles of SHR6390 in
absence and presence of prior administration of proton pump inhibitor Omeprazole. The
increased gastric pH achieved by the treatment with multiple doses of Omeprazole might affect
the absorption process of SHR6390.